Controlled extended octenidine release from a bacterial nanocellulose/Poloxamer hybrid system

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 112, Issue , 2017, Pages 164-176

  Alkhatib, Y ^a   Dewaldt, M ^a   Moritz, S ^a   Nitzsche, R ^b   Kralisch, D ^a   Fischer, D ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Malvern Instruments GmbH   (Germany)

Author keywords

Bacterial nanocellulose; Hydropolymer; Octenidine; Poloxamer; Wound dressing

Indexed keywords

BACTERIAL NANOCELLULOSE; CELLULOSE; OCTENIDINE; POLOXAMER; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; DRUG CARRIER; NANOPARTICLE; PYRIDINE DERIVATIVE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BIOCOMPATIBILITY; COMPRESSION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STABILITY; GEL; HYBRID; MICELLE; NONHUMAN; PHYSICAL CHEMISTRY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SURFACE CHARGE; VISCOSITY; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PROTEOBACTERIA;

CELLULOSE; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; POLOXAMER; PROTEOBACTERIA; PSEUDOMONAS AERUGINOSA; PYRIDINES; STAPHYLOCOCCUS AUREUS;

EID: 85000717958     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2016.11.025     Document Type: Article

References (62)

1. [1] Klemm, D., Schumann, D., Kramer, F., Heßler, N., Hornung, M., Schmauder, H.-P., Marsch, S., Nanocelluloses as innovative polymers in research and application. Klemm, D., (eds.) Polysaccharides II, 2006, Springer, Berlin, Heidelberg, Germany, 49–96.
2. [2] Klemm, D., Heublein, B., Fink, H.P., Bohn, A., Cellulose: fascinating biopolymer and sustainable raw material. Angew. Chem. 44 (2005), 3358–3393.
3. [3] Jozala, A.F., de Lencastre-Novaes, L.C., Lopes, A.M., de Carvalho Santos-Ebinuma, V., Mazzola, P.G., Pessoa-Jr, A., Grotto, D., Gerenutti, M., Chaud, M.V., Bacterial nanocellulose production and application: a 10-year overview. Appl. Microbiol. Biotechnol. 100 (2016), 2063–2072.
4. [4] Moritz, S., Wiegand, C., Wesarg, F., Hessler, N., Müller, F.A., Kralisch, D., Hipler, U.-C., Fischer, D., Active wound dressings based on bacterial nanocellulose as drug delivery system for octenidine. Int. J. Pharm. 471 (2014), 45–55.
5. [5] Trovatti, E., Freire, C.S.R., Pinto, P.C., Almeida, I.F., Costa, P., Silvestre, A.J.D., Neto, C.P., Rosado, C., Bacterial cellulose membranes applied in topical and transdermal delivery of lidocaine hydrochloride and ibuprofen: in vitro diffusion studies. Int. J. Pharm. 435 (2012), 83–87.
6. [6] Wiegand, C., Moritz, S., Hessler, N., Kralisch, D., Wesarg, F., Müller, F.A., Fischer, D., Hipler, U.-C., Antimicrobial functionalization of bacterial nanocellulose by loading with polihexanide and povidone-iodine. J. Mater. Sci. - Mater. Med. 26 (2015), 1–14.
7. [7] Andrade, F.K., Alexandre, N., Amorim, I., Gartner, F., Maurício, A.C., Luís, A.L., Gama, M., Studies on the biocompatibility of bacterial cellulose. J. Bioactive Compat. Pol. 28 (2013), 97–112.
8. [8] Müller, A., Ni, Z., Hessler, N., Wesarg, F., Müller, F.A., Kralisch, D., Fischer, D., The biopolymer bacterial nanocellulose as drug delivery system: investigation of drug loading and release using the model protein albumin. J. Pharm. Sci. 102 (2013), 579–592.
9. [9] Numata, Y., Mazzarino, L., Borsali, R., A slow-release system of bacterial cellulose gel and nanoparticles for hydrophobic active ingredients. Int. J. Pharm. 486 (2015), 217–225.
10. [10] Pourali, P., Yahyaei, B., Ajoudanifar, H., Taheri, R., Alavi, H., Hoseini, A., Impregnation of the bacterial cellulose membrane with biologically produced silver nanoparticles. Curr. Microbiol. 69 (2014), 785–793.
11. [11] Trovatti, E., Silva, N.H., Duarte, I.F., Rosado, C.F., Almeida, I.F., Costa, P., Freire, C.S., Silvestre, A.J., Neto, C.P., Biocellulose membranes as supports for dermal release of lidocaine. Biomacromolecules 12 (2011), 4162–4168.
12. [12] Berndt, S., Wesarg, F., Wiegand, C., Kralisch, D., Müller, F., Antimicrobial porous hybrids consisting of bacterial nanocellulose and silver nanoparticles. Cellulose 20 (2013), 771–783.
13. [13] Dumortier, G., Grossiord, J., Agnely, F., Chaumeil, J., A review of Poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm. Res. 23 (2006), 2709–2728.
14. [14] Kabanov, A.V., Batrakova, E.V., Alakhov, V.Y., Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release 82 (2002), 189–212.
15. [15] Lopes, J.R., Loh, W., Investigation of self-assembly and micelle polarity for a wide range of ethylene oxide−propylene oxide−ethylene oxide block copolymers in water. Langmuir 14 (1998), 750–756.
16. [16] Saxena, V., Hussain, M.D., Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer. Int. J. Nanomed. 7 (2012), 713–721.
17. [17] Dang, Q.F., Yan, J.Q., Li, J.J., Cheng, X.J., Liu, C.S., Chen, X.G., Controlled gelation temperature, pore diameter and degradation of a highly porous chitosan-based hydrogel. Carbohydr. Polym. 83 (2011), 171–178.
18. [18] Gilbert, J.C., Richardson, J.L., Davies, M.C., Palin, K.J., Hadgraft, J., The effect of solutes and polymers on the gelation properties of Pluronic F-127 solutions for controlled drug delivery. J. Control. Release 5 (1987), 113–118.
19. [19] Ritger, P.L., Peppas, N.A., A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Release 5 (1987), 37–42.
20. [20] Mao, Y., Thompson, M.J., Wang, Q., Tsai, E.W., Quantitation of Poloxamers in pharmaceutical formulations using size exclusion chromatography and colorimetric methods. J. Pharm. Biomed. Anal. 35 (2004), 1127–1142.
21. [21] Kralisch, D., Hessler, N., Klemm, D., Erdmann, R., Schmidt, W., White biotechnology for cellulose manufacturing – the HoLiR concept. Biotechnol. Bioeng. 105 (2010), 740–747.
22. [22] Klemm, D., Philipp, B., Heinze, T., Heinze, U., Wagenknecht, W., General considerations on structure and reactivity of cellulose: section 2.1–2.1.4. Comprehensive Cellulose Chemistry, 2004, Wiley Online Library, 9–29.
23. [23] Müller, R., Stranik, O., Schlenk, F., Werner, S., Malsch, D., Fischer, D., Fritzsche, W., Optical detection of nanoparticle agglomeration in a living system under the influence of a magnetic field. J. Magn. Magn. Mater. 380 (2015), 61–65.
24. [24] Hamburger, V., Hamilton, H.L., A series of normal stages in the development of the chick embryo. J. Morphol. 88 (1951), 49–92.
25. [25] Wiegand, C., Abel, M., Ruth, P., Hipler, U.-C., HaCaT keratinocytes in co-culture with Staphylococcus aureus can be protected from bacterial damage by polihexanide. Wound Repair Regen. 17 (2009), 730–738.
26. [26] CLSI VET01-A4, Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals. Approved standard - fourth ed., 2013, Clinical and Laboratory Standards Institute.
27. [27] Ricci, E., Lunardi, L., Nanclares, D., Marchetti, J., Sustained release of lidocaine from Poloxamer 407 gels. Int. J. Pharm. 288 (2005), 235–244.
28. [28] Alexandridis, P., Holzwarth, J.F., Hatton, T.A., Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solutions: thermodynamics of copolymer association. Macromolecules 27 (1994), 2414–2425.
29. [29] A.Von der Höh, C. Abels, U. Knie, Gel for Treating Wounds, EP 1982696 B1, 2010.
30. [30] Sezgin, Z., Yuksel, N., Baykara, T., Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur. J. Pharm. Biopharm. 64 (2006), 261–268.
31. [31] Sharma, P.K., Bhatia, S.R., Effect of anti-inflammatories on Pluronic F127: micellar assembly, gelation and partitioning. Int. J. Pharm. 278 (2004), 361–377.
32. [32] Kelarakis, A., Giannelis, E.P., Nafion as cosurfactant: solubilization of nafion in water in the presence of Pluronics. Langmuir 27 (2011), 554–560.
33. [33] Ju, C., Sun, J., Zi, P., Jin, X., Zhang, C., Thermosensitive micelles-hydrogel hybrid system based on Poloxamer 407 for localized delivery of paclitaxel. J. Pharm. Sci. 102 (2013), 2707–2717.
34. [34] Ivanova, R., Alexandridis, P., Lindman, B., Interaction of Poloxamer block copolymers with cosolvents and surfactants. Colloids Surf. A 183–185 (2001), 41–53.
35. [35] Alexandridis, P., Yang, L., SANS investigation of polyether block copolymer micelle structure in mixed solvents of water and formamide, ethanol or glycerol. Macromolecules 33 (2000), 5574–5587.
36. [36] Cho, C.W., Shin, S.C., Oh, I.J., Thermorheologic properties of aqueous solutions and gels of Poloxamer 407. Drug Dev. Ind. Pharm. 23 (1997), 1227–1232.
37. [37] White, D.G., Brown, R.M. Jr, Prospects for the commercialization of the biosynthesis of microbial cellulose. Cellulose and Wood-Chemistry and Technology, vol. 573, 1989, Wiley, New York, 573–590.
38. [38] Müller, A., Wesarg, F., Hessler, N., Müller, F.A., Kralisch, D., Fischer, D., Loading of bacterial nanocellulose hydrogels with proteins using a high-speed technique. Carbohydr. Polym. 106 (2014), 410–413.
39. [39] Pavaloiu, R.-D., Stoica, A., Stroescu, M., Dobre, T., Controlled release of amoxicillin from bacterial cellulose membranes. Open Chem. 12 (2014), 962–967.
40. [40] Cai, Z., Kim, J., Preparation and characterization of novel bacterial cellulose/gelatin scaffold for tissue regeneration using bacterial cellulose hydrogel. J. Nanotechnol. Eng. Med., 1, 2010 021002/021001-021002/021006.
41. [41] Haimer, E., Wendland, M., Schlufter, K., Frankenfeld, K., Miethe, P., Potthast, A., Rosenau, T., Liebner, F., Loading of bacterial cellulose aerogels with bioactive compounds by antisolvent precipitation with supercritical carbon dioxide. Macromole. Symp. 294 (2010), 64–74.
42. [42] Anderson, B.C., Pandit, N.K., Mallapragada, S.K., Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels. J. Control. Release 70 (2001), 157–167.
43. [43] Nasir, F., Iqbal, Z., Khan, J.A., Khan, A., Khuda, F., Ahmad, L., Khan, A., Khan, A., Dayoo, A., Roohullah, Development and evaluation of diclofenac sodium thermorevesible subcutaneous drug delivery system. Int. J. Pharm. 439 (2012), 120–126.
44. [44] Gilbert, J.C., Hadgraft, J., Bye, A., Brookes, L.G., Drug release from Pluronic F-127 gels. Int. J. Pharm. 32 (1986), 223–228.
45. [45] Zhang, L., Parsons, D.L., Navarre, C., Kompella, U.B., Development and in vitro evaluation of sustained release Poloxamer 407 (P407) gel formulations of ceftiofur. J. Control. Release 85 (2002), 73–81.
46. [46] Ricci, E., Bentley, M., Farah, M., Bretas, R., Marchetti, J., Rheological characterization of Poloxamer 407 lidocaine hydrochloride gels. Eur. J. Pharm. Sci. 17 (2002), 161–167.
47. [47] Nakayama, A., Kakugo, A., Gong, J.P., Osada, Y., Takai, M., Erata, T., Kawano, S., High mechanical strength double-network hydrogel with bacterial cellulose. Adv. Funct. Mater. 14 (2004), 1124–1128.
48. [48] Hagiwara, Y., Putra, A., Kakugo, A., Furukawa, H., Gong, J.P., Ligament-like tough double-network hydrogel based on bacterial cellulose. Cellulose 17 (2010), 93–101.
49. [49] Sulaeva, I., Henniges, U., Rosenau, T., Potthast, A., Bacterial cellulose as a material for wound treatment: Properties and modifications. A review. Biotechnol. Adv., 2015.
50. [50] Kramer, F., Klemm, D., Schumann, D., Hessler, N., Wesarg, F., Fried, W., Stadermann, D., Nanocellulose polymer composites as innovative pool for (bio)material development. Macromol. Symp. 244 (2006), 136–148.
51. [51] ICCVAM Test Method Evaluation Report: Appendix G-ICCVAM Recommended HET-CAM Test Method Protocol, 2006.
52. [52] Vargas, A., Zeisser-Labouebe, M., Lange, N., Gurny, R., Delie, F., The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. Adv. Drug Deliv. Rev. 59 (2007), 1162–1176.
53. [53] Guidance for Industry: Chronic Cutaneous Ulcer and Burn Wounds – Developing Products for Treatment, U.S. Department of Health and Human Services – Food and Drug Administration, 2006.
54. [54] Marquardt, C., Matuschek, E., Bölke, E., Gerber, P.A., Peiper, M., Seydlitz-Kurzbach, J.V., Buhren, B.A., van Griensven, M., Budach, W., Hassan, M., Kukova, G., Mota, R., Höfer, D., Orth, K., Fleischmann, W., Evaluation of the tissue toxicity of antiseptics by the hen's egg test on the chorioallantoic membrane (HET-CAM). Eur. J. Med. Res. 15 (2010), 204–209.
55. [55] Jeong, B., Bae, Y.H., Lee, D.S., Kim, S.W., Biodegradable block-copolymers as injectable drug delivery systems. Nature 388 (1997), 860–862.
56. [56] Napavichayanun, S., Yamdech, R., Aramwit, P., The safety and efficacy of bacterial nanocellulose wound dressing incorporating sericin and polyhexamethylene biguanide: in vitro, in vivo and clinical studies. Arch. Dermatol. Res. 308 (2016), 123–132.
57. [57] Bowler, P.G., Duerden, B.I., Armstrong, D.G., Wound microbiology and associated approaches to wound management. Clin. Microbiol. Rev. 14 (2001), 244–269.
58. [58] Stocks, S., Mechanism and use of the commercially available viability stain, BacLight. Cytometry Part A 61 (2004), 189–195.
59. [59] Jones, D.S., Bruschi, M.L., de Freitas, O., Gremião, M.P.D., Lara, E.H.G., Andrews, G.P., Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of Poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity. Int. J. Pharm. 372 (2009), 49–58.
60. [60] Gratieri, T., Gelfuso, G.M., Rocha, E.M., Sarmento, V.H., de Freitas, O., Lopez, R.F.V., A Poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur. J. Pharm. Biopharm. 75 (2010), 186–193.
61. [61] Bonacucina, G., Spina, M., Misici-Falzi, M., Cespi, M., Pucciarelli, S., Angeletti, M., Palmieri, G.F., Effect of hydroxypropyl β-cyclodextrin on the self-assembling and thermogelation properties of Poloxamer 407. Eur. J. Pharm. Sci. 32 (2007), 115–122.
62. [62] Edsman, K., Carlfors, J., Petersson, R., Rheological evaluation of Poloxamer as an in situ gel for ophthalmic use. Eur. J. Pharm. Sci. 6 (1998), 105–112.